Cite

HARVARD Citation

    Parmar, S. et al. (2021). Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3-Mutated Metastatic Breast Cancer. JCO precision oncology. p. . [Online]. 
  
Back to record